LAUREN COFFIN: Open Payments
NPI 1457913386 · HUDSON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,585 in 64 payments from 15 companies in 2025. Trend: 2023 $555 · 2024 $1,379 · 2025 $1,585
Food & beverage: $1,585
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $292 |
| Valinor Pharma, LLC | 16 | $272 |
| Boston Scientific Corporation | 4 | $219 |
| ABBVIE INC. | 6 | $152 |
| Globus Medical, Inc. | 4 | $148 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $121 |
| Lundbeck LLC | 4 | $108 |
| Collegium Pharmaceutical, Inc. | 5 | $86 |
| Nalu Medical, Inc. | 1 | $49 |
| TerSera Therapeutics LLC | 1 | $30 |
Products named: RELISTOR, MOVANTIK, Intracept, Senza, JOURNAVX, VYEPTI, BOTOX, XTAMPZA.
Industry payments across MA — which companies pay providers there.
